Harrow, Inc. (HROW)
NASDAQ: HROW · Real-Time Price · USD
26.28
-0.39 (-1.44%)
At close: May 13, 2025, 4:00 PM
26.04
-0.23 (-0.88%)
Pre-market: May 14, 2025, 5:02 AM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Innovative Ophthalmic Therapies
130.19M
Log In
Log In
Log In
Log In
Upgrade
Innovative Ophthalmic Therapies Growth
46.95%
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical Compounding
-
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical Compounding Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
130.19M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
46.95%
Log In
Log In
Log In
Log In
Upgrade